🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators preliminary data suggests that FOLFOX-A may have equal or...
Status
Completed
Location
Roxanne Wood
Start Date
2014-02-01
Trial ID
NCT02022033
Treatments Being Tested
The purpose of this study is to generate safety, reactogenicity (assessment...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-08-05
Trial ID
NCT04026009
This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Status
Recruiting
Location
The fourth hospital of Hebei Medical University
Start Date
2024-11-15
Trial ID
NCT06576921
Treatments Being Tested
This trial is a Phase II study. All patients are resectable Gastric or Gast...
Status
Recruiting
Location
Tianjin Provincial Tumor Hospital
Start Date
2023-11-13
Trial ID
NCT05960955
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as doxorubicin, cyclophosphamid...
Status
Active Not Recruiting
Location
Regional Medical Center
Start Date
2003-11
Trial ID
NCT00070564
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, w...
Status
Completed
Location
Fairview Southdale Hospital
Start Date
2009-04
Trial ID
NCT00895414
Treatments Being Tested
The purpose of this research study is to find out what effects (good and ba...
Status
Completed
Location
Birmingham Hematology and Oncology
Start Date
2007-06
Trial ID
NCT00493649
This is a prospective, single-arm trial. The main purpose of the study is t...
Status
Recruiting
Location
Zhejiang Provincial People's Hospital
Start Date
2024-11-15
Trial ID
NCT06722911
Treatments Being Tested
This phase II trial examines the use of blood-based biomarkers is to help i...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-02-21
Trial ID
NCT05541016
Treatments Being Tested
The GI-4000 therapeutic vaccine or placebo will be injected under the skin ...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2006-01
Trial ID
NCT00300950
Treatments Being Tested